UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046484
Receipt number R000053038
Scientific Title The actual condition survey of the scalp and a home use test to verify the scalp improvement effect of shampoos
Date of disclosure of the study information 2021/12/29
Last modified on 2022/02/25 15:42:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The actual condition survey of the scalp and a home use test of shampoos

Acronym

The actual condition survey of the scalp and a home use test of shampoos

Scientific Title

The actual condition survey of the scalp and a home use test to verify the scalp improvement effect of shampoos

Scientific Title:Acronym

The actual condition survey of the scalp and a home use test of shampoos

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate scalp conditions and evaluate the scalp improvement effect of shampoos

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Scalp physicality, surface ingredients
After use of placebo shampoo for 4 weeks, evaluate the dandruff and scalp itchiness before and after use of test shampoos for 4 weeks

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Use shampoo A on head once a day for 4 weeks each

Interventions/Control_2

Use shampoo B on head once a day for 4 weeks each

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

49 years-old >=

Gender

Female

Key inclusion criteria

-Healthy females aged 20 to 49 living in Tokyo suburbs
-Subjects who wash their hair more than 6 days a week
-Subjects who can accommodate restrictions (prohibition of hair coloring, bleaching, perm) during the period of participation
-Subjects who can provide consent on a voluntary basis before this study starts

Key exclusion criteria

-Subjects with suspected skin allergy, cutaneous hypersensitivity
-Subjects with severe hay fever
-Subjects who could cause skin allergy by shampoo, hair conditioner or scalp lotion
-Subjects whose skin turns red with ethanol
-Subjects with external injury, surgical treatments on test area
-Subjects with atopic dermatitis, seborrheic dermatitis on test area
-Subjects with highly exposed to sun light
-Subjects whose hair was chemically treated within one week before the start of this study
-Subjects who have rapid hair loss or hair missing in a patchy shape
-Subjects who use pharmaceuticals, hair growth agents, tonics, moisturizers, etc. on the scalp
-Subjects who regularly take vitamins and other supplements that can exhibit anti-inflammatory and dandruff-related efficacy
-Subjects who use products containing carbon dioxide (shampoos, hair conditioners, etc.) on the scalp
-Subjects who are pregnant or willing to become pregnant or are breastfeeding during the period of participation
-Subjects who are going to the hospital or taking medication due to chronic illness
-Subjects who have had strong symptoms such as shortness of breath (difficulty breathing), strong fatigue, or high fever within the past 2 weeks
-Subjects who are considered to have had close contact with a COVID-19 patient from the public health center
-Subjects who have get a COVID-19 vaccine within the past one week.
-Subjects or her family members work for a company related to the manufacture and sale of pharmaceuticals, cosmetics, toiletry products, etc.
-Subjects who participate in other surveys or studies
-Subjects who plan to participate in other studies or surveys during the study period
-Subjects deemed inappropriate to participate in this study by the person involved in the study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Yoshida

Organization

Kao Corporation

Division name

R&D, Hair Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9872

Email

yoshida.hiroshi1@kao.com


Public contact

Name of contact person

1st name Atsuko
Middle name
Last name Ebato

Organization

Kao Corporation

Division name

R&D, Hair Care Products Research

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-9872

Homepage URL


Email

ebato.atsuko@kao.com


Sponsor or person

Institute

SOUKEN

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

Tel

+81-3-5630-7263

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社SOUKEN(東京都)


Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 12 Month 24 Day

Date of IRB

2021 Year 12 Month 24 Day

Anticipated trial start date

2021 Year 12 Month 30 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 12 Month 27 Day

Last modified on

2022 Year 02 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053038